Milestones in myoclonus

Movement Disorders

Volumn 26, Issue 6, 2011, Pages 1142-1148

  Shibasaki, Hiroshi ^a   Thompson, Philip D ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Clinical features; Molecular genetics; Myoclonus; Physiology

Indexed keywords

ETIRACETAM; OXYBATE SODIUM;

BRAIN CORTEX; BRAIN STEM; CEREBELLUM DISEASE; DISEASE CLASSIFICATION; ESSENTIAL TREMOR; FLAPPING TREMOR; GENETICS; HUMAN; KIDNEY FAILURE; MOLECULAR BIOLOGY; MYOCLONUS; MYOCLONUS DYSTONIA; MYOCLONUS EPILEPSY; NEUROPATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREMOR;

ANIMALS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MYOCLONUS;

EID: 79957584204     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23673     Document Type: Review

References (104)

1. Friedreich N. Paramyoclonus multiplex. Neuropathologische Beobachtungen. Arch Path Anat (Virchow Arch) 1881; 86: 421-434.
2. Ginker RR, Serota H, Stein SI. Myoclonic epilepsy. Arch Neurol Psychiatry 1938; 40: 968-980.
3. Dawson GD. Investigations on a patient subject to myoclonic seizures after sensory stimulation. J Neurol Neurosurg Psychiatry 1947; 10: 141-162.
4. Sutton GG, Mayer RF. Focal reflex myoclonus. J Neurol Neurosurg Psychiatry 1974; 37: 207-217.
5. Shibasaki H, Kuroiwa Y. Electroencephalographic correlates of myoclonus. Electroenceph Clin Neurophysiol 1975; 39: 455-463.
6. Chadwick D, Hallett M, Harris R, et al. Clinical, biochemical and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Brain 1977; 100: 455-487.
7. Shibasaki H, Yamashita Y, Kuroiwa Y. Electroencephalographic studies of myoclonus: myoclonus-related cortical spikes and high amplitude somatosensory evoked potentials. Brain 1978; 101: 447-460.
8. Hallett M, Chadwick D, Marsden CD. Cortical reflex myoclonus. Neurology 1979; 29: 1107-1125.
9. Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 1963; 86: 111-136.
10. Brown P, Rothwell JC, Thompson PD, Britton TC, Day BL, Marsden CD. The hyperekplexias and their relationship to the normal startle reflex. Brain 1991; 114: 1903-1928.
11. Inazuki G, Naito H, Ohama E, et al. A clinical study and neuropathological findings of a familial disease with myoclonus and epilepsy-familial essential myoclonus and epilepsy. Psychiatr Neurol Jpn 1990; 92: 1-21.
12. Yasuda T. Benign adult familial myoclonic epilepsy (BAFME). Kawasaki Med J 1991; 17: 1-13.
13. Ikeda A, Kakigi R, Funai N, et al. Cortical tremor: a variant of cortical reflex myoclonus. Neurology 1990; 40: 1561-1565.
14. Terada K, Ikeda A, Mima T, et al. Familial cortical myoclonic tremor as a unique form of cortical reflex myoclonus. Mov Disord 1997; 12: 370-377.
15. de Falco FA, Striano P, de Falco A, et al. Benign adult familial myoclonic epilepsy. Genetic heterogeneity and allelism with ADCME. Neurology 2003; 60: 1381-1385.
16. Striano P, Chifari R, Striano S, et al. A new benign adult familial myoclonic epilepsy (BAFME) pedigree suggesting linkage to chromosome 2p11.1-q12.2. Epilepsia 2004; 45: 190-192.
17. Suppa A, Berardelli A, Brancati F, et al. Clinical, neuropsychological, neurophysiologic, and genetic features of a new Italian pedigree with familial cortical myoclonic tremor with epilepsy. Epilepsia 2009; 50: 1284-1288.
18. van Rootselaar AF, Aronica E, Steur ENHJ, et al. Familial cortical tremor with epilepsy and cerebellar pathological findings. Mov Disord 2004; 19: 213-217.
19. Depienne C, Magnin E, Bouteiller D, et al. Familial cortical myoclonic tremor with epilepsy: The third locus (FCMTE3) maps to 5p. Neurology 2010; 74: 2000-2003.
20. Bhadwar A, Berkovic S, Dowling JP, et al. Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder. Brain 2004; 127: 2173-2182.
21. Quinn NP. Essential myoclonus and myoclonic dystonia. Mov Disord 1996; 11: 119-124.
22. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001; 29: 66-69.
23. Schuele B, Kock N, Svetel M, et al. Genetic heterogeneity in ten families with myoclonus-dystonia. J Neurol Neurosurg Psychiatry 2004; 75: 1181-1185.
24. Roze E, Apartis E, Clot F, et al. Myoclonus-dystonia. Clinical and electrophysiologic pattern related to SGCE mutations. Neurology 2008; 70: 1010-1016.
25. Nardocci N, Zorzi G, Barzaghi C, et al. Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord 2008; 23: 28-34.
26. Kinugawa K, Vidhailet M, Clot F, Apartis E, Grabli D, Roze E. Myoclonus-dystonia: an update. Mov Disord 2009; 24: 479-489.
27. Asmus F, Langseth A, Doherty E, et al. "Jerky" dystonia in children: spectrum of phenotypes and genetic testing. Mov Disord 2009; 24: 702-779.
28. O'Riordan S, Ozelius LJ, De Carvalho Aguiar P, et al. Inherited myoclonus-dystonia and epilepsy: Further evidence of an association? Mov Disord 2004; 19: 1456-1459.
29. Marelli C, Canafoglia L, Zibordi F, et al. A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov Disord 2008; 23: 2041-2048.
30. Li J-Y, Cunic DI, Paradiso G, et al. Electrophysiological features of myoclonus-dystonia. Mov Disord 2008; 23: 2055-2061.
31. van der Salm SM, van Rootselaar AF, Foncke EM, et al. Normal cortical excitability in Myoclonus-Dystonia-a TMS study. Exp Neurol 2009; 216: 300-305.
32. Lapresle J. Rhythmic palatal myoclonus and the dentato-olivary pathway. J Neurol 1979; 220: 223-230.
33. Deuschl G, Toro C, Valls-Sole J, et al. Symptomatic and essential palatal tremor. I. Clinical, physiological and MRI analysis. Brain 1994; 117: 775-788.
34. Deuschl G, Toro C, Hallett M. Symptomatic and essential palatal tremor. 2. Differences of palatal movements. Mov Disord 1994; 9: 676-678.
35. Williams DR. Psychogenic palatal tremor. Mov Disord 2004; 19: 333-335.
36. Pirio Richardson S, Mari Z, Matsuhashi M, Hallett M. Psychogenic palatal tremor. Mov Disord 2006, 21, 274-276.
37. Brown P, Thompson PD, Rothwell JC, et al. Axial myoclonus of propriospinal origin. Brain 1991; 114: 197-214.
38. Brown P, Rothwell JC, Thompson PD, et al. Propriospinal myoclonus: evidence for spinal "pattern" generators in humans. Mov Disord 1994; 5: 571-576.
39. Roze E, Bounolleau P, Ducreux D, et al. Propriospinal myoclonus revisited: Clinical, neurophysiologic, and neuroradiologic findings. Neurology 2009; 72: 1301-1309.
40. Brown P, Thompson PD. Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor. Mov Disord 2001; 16: 595-599.
41. Williams DR, Cowey M, Day B. Psychogenic propriospinal myoclonus. Mov Disord 2008; 23: 1312-1313.
42. Esposito M, Edwards MJ, Bhatia KP, et al. Idiopathic spinal myoclonus: a clinical and neurophysiological assessment of a movement disorder of uncertain origin. Mov Disord 2009; 2344-2349.
43. Kang S, Sohn Y. Electromyography patterns of propriospinal myoclonus can be mimicked voluntarily. Mov Disord 2006; 21: 1241-1244.
44. Shibasaki H, Yamashita Y, Neshige R, et al. Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy. Brain 1985; 108: 225-240.
45. Kakigi R, Shibasaki H. Generator mechanisms of giant somatosensory evoked potentials in cortical reflex myoclonus. Brain 1987; 110: 1359-1373.
46. Shibasaki H, Kakigi R, Ikeda A. Scalp topography of giant SEP and premyoclonus spike in cortical reflex myoclonus. Electroenceph Clin Neurophysiol 1991; 81: 31-37.
47. Ikeda A, Shibasaki H, Nagamine T, et al. Peri-rolandic and fronto-parietal components of scalp-recorded giant SEPs in cortical myoclonus. Electroenceph Clin Neurophysiol 1995; 96: 300-309.
48. Shibasaki H, Hallett M. AAEE monograph #30: electrophysiological studies of myoclonus. Muscle Nerve 2005; 31: 157-174.
49. Hitomi T, Ikeda A, Matsumoto R, et al. Generators and temporal succesion of giant somatosensory evoked potentials in cortical reflex myoclonus: epicortical recording from sensorimotor cortex. Clin Neurophysiol 2006; 117: 1481-1486.
50. Brown P, Day BL, Rothwell JC, et al. Intrahemispheric and interhemispheric spread of cerebral cortical myoclonic activity and its relevance to epilepsy. Brain 1991; 114: 2333-2351.
51. Shibasaki H, Neshige R. Photic cortical reflex myoclonus. Ann Neurol 1987; 22: 252-257.
52. Mima T, Nagamine T, Ikeda A, et al. Pathogenesis of cortical myoclonus studied by magnetoencephalography. Ann Neurol 1998; 43: 598-607.
53. Mima T, Nagamine T, Nishitani, N, et al. Cortical myoclonus: sensorimotor hyperexcitability. Neurology 1998; 50: 933-942.
54. Brown P, Farmer SF, Halliday DM, et al. Coherent cortical and muscle discharge in cortical myoclonus. Brain 1999; 122: 461-472.
55. Young RR, Shahani BT. Asterixis: one type of negative myoclonus. Adv Neurol 1986; 43: 137-156.
56. Shibasaki H. Pathophysiology of negative myoclonus and asterixis. Adv Neurol 1995; 67: 199-209.
57. Ugawa Y, Shimpo T, Mannen T. Physiological analysis of asterixis: silent period locked averaging. J Neurol Neurosurg Psychiatry 1989; 52: 89-92.
58. Artieda J, Muruzabal J, Larumbe R, et al. Cortical mechanisms mediating asterixis. Mov Disord 1992: 7: 209-216.
59. Shibasaki H, Ikeda A, Nagamine T, et al. Cortical reflex negative myoclonus. Brain 1994; 117: 477-486.
60. Ikeda A, Ohara S, Matsumoto R, et al. Role of primary sensorimotor cortices in generating inhibitory motor response in humans. Brain 2000; 123: 1710-1721.
61. Hashimoto S, Kawamura J, Yamamoto T, et al. Transient myoclonic state with asterixis in elderly patients: a new syndrome? J Neurol. Sci 1992; 109: 132-139.
62. Huang YZ, Lai SC, Lu CS, et al. Abnormal cortical excitability with preserved brainstem and spinal reflexes in sialidosis type I. Clin Neurophysiol 2008; 119: 1042-1050.
63. Hanajima R, Okabe S, Terao Y, et al. Difference in intracortical inhibition of the motor cortex between cortical myoclonus and focal hand dystonia. Clin Neurophysiol 2008; 119: 1400-1407.
64. Thompson PD, Day BL, Rothwell JC, et al. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 1994; 117: 1197-1207.
65. Valzania F, Strafella AP, Tropeani A, et al. Facilitation of rhythmic events in progressive myoclonus epilepsy: a transcranial magnetic stimulation study. Clin Neurophysiol 1999; 110: 152-157.
66. Hanajima R, Ugawa Y, Okabe S, et al. Interhemispheric interaction between the hand motor areas in patients with cortical myoclonus. Clin Neurophysiol 2001; 112: 623-626.
67. Thompson, PD, Rothwell JC, Brown P, Day BL, Asselman P. Transcallosal and intracortical spread of activity following cortical stimulation in a patient with generalized cortical myoclonus. J Physiol (Lond) 1993; 459: 64P.
68. van Rootselaar A, Aronica E, Steur ENHJ, et al. Familial cortical tremor with epilepsy and cerebellar pathological findings. Mov Disord 2004; 19: 213-217.
69. van Rootselaar AF, van der Salm SM, Bour LJ, et al. Decreased cortical inhibition and yet cerebellar pathology in 'familial cortical myoclonic tremor with epilepsy.' Mov Disord 2007; 22: 2378-2385.
70. Tijssen MAJ, Thom M, Ellison DW, et al. Cortical myoclonus and cerebellar pathology. Neurology 2000; 54: 1350-1356.
71. Lehesjoki A-E. Molecular background of progressive myoclonus epilepsy. EMBO J 2003; 22: 3473-3478.
72. Shahwan A, Farrell M, Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 2005; 4: 239-248.
73. De Siqueira LFM. Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects. J Neurol 2010; 257: 1612-1619.
74. Plaster NM, Uyama E, Uchino M, et al. Genetic localization of the familial adult myoclonic epilepsy (FAME) gene o chromosome 8q24. Neurology 1999; 53: 1180-1183.
75. Mikami M, Yasuda T, Terao A, et al. Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1. Am J Hum Genet 1999; 65: 745-751.
76. Shimizu A, Asakawa S, Sasaki T, et al. A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1. Biochem Biophys Res Comm 2003; 309: 143-154.
77. Berkovic SF, Dibbens LM, Oshlack A, et al. Array based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am J Hum Genet 2008; 82: 673-684.
78. Dibbens LM, Berkovic SF, Gambardella A, et al. SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Ann Neurol 2009; 66: 532-536.
79. Brown P, Rothwell JC, Thompson PD, et al. The hyperekplexias and their relationship to the normal startle reflex. Brain 1991; 114: 1903-1928.
80. Thompson PD, Colebatch JG, Brown P, et al. Voluntary stimulus-sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes. Mov Disord 1992; 7: 257-262.
81. Chokroverty S, Walczak T, Hening W. Human startle reflex: technique and criteria for abnormal response. Electroenceph Clin Neurophysiol 1992; 85: 236-242.
82. Ryan SG, Sherman SL, Terry JC, et al. Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis. Ann Neurol 1992; 31: 663-668.
83. Shiang R, Ryan SG, Zhu YZ, et al. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 1993; 5: 351-358.
84. Rajendra S, Lynch JW, Pierce KD, et al. Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor. J Biol Chem 1994; 269: 18739-18742.
85. Tijssen MA, Shiang R, van Deutekom J, et al. Molecular genetic reevaluation of the Dutch hyperekplexia family. Arch Neurol 1995; 52: 578-582.
86. Shiang R, Ryan SG, Zhu YZ, et al. Mutational analysis of familial and sporadic hyperekplexia. Ann Neurol 1995; 38: 85-91.
87. Rees MI, Lewis TM, Kwok JB, et al. Hyperekplexia associated with compound heterozygote mutations in the beta subunit of the human inhibitory glycine receptor (GLRB) Hum Mol Genet 2002; 11: 853-860.
88. Rees MI, Harvey K, Ward H, et al. Isoform heterogeneity of the human gephyrin gene (GPHN) binding domains to the glycine receptor and mutation analysis in hyperekplexia. J Biol Chem 2003; 278: 853-860.
89. Harvey K, Duguid I, Alldred M, et al. The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J Neurosci 2004; 24: 24688-24696.
90. Rees MI, Harvey K, Pearce BR, et al. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat Genet 2006; 38: 801-806.
91. Terwinghe G, Daumerie J, Nicaise C, Rosillon O. Therapeutic effect of piracetam in a case of posthypoxic action myoclonus. Acta Neurol Belg 1978; 78: 30-36.
92. Obeso JA, Artieda J, Quinn N, et al. Pircetam in the treatment of different types of myoclonus. Clin Neuropharmacol 1988; 11: 529-536.
93. Brown P, Steiger MJ, Thompson PD, et al. Effectiveness of piracetam in cortical myoclonus. Mov Disord 1993; 8: 63-68.
94. Ikeda A, Shibasaki H, Tashiro K, et al. Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. Mov Disord 1996; 11: 691-700.
95. Crest C, Dupont S, Leguern E, et al. Levetiracetam in progressive myoclonus epilepsy. An exploratory study in 9 patients. Neurology 2004; 62: 640-643.
96. Magaudda A, Gelisse P, Genton P. Antimyoclonic effect of levetircetam in 13 patients with Unverricht-Lundborg disease: clinical observaions. Epilepsia 2004; 45: 678-681.
97. Striano P, Manganelli F, Boccella P, et al. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord 2005; 20: 1610-1655.
98. Mancuso M, Galli R, Pizzanelli C, et al. Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci 2006; 243: 97-99.
99. Frucht SJ, Bordlon Y, Houghton WH, et al. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-response movement disorders. Mov Disord 2005; 20: 1330-1337.
100. Frucht SJ, Houghton WC, Bordelon Y, et al. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology 2005; 65: 1967-1970.
101. Tatu L, Moulin T, Martin V, et al. Unilateral pure thalamic asterixis: Clinical, electromyographic, and topographic patterns. Neurology 2000; 54: 2339-2342.
102. Truong DD, Matsumoto RR, Schwartz PH, et al. Novel rat cardiac arrest model of posthypoxic myoclonus. Mov Disord 1994; 9: 201-206.
103. Matsumoto RR, Hussoung MJ, Truong DD. Effects of selective serotonergic ligands on posthypoxic audiogenic myoclonus. Mov Disord 1995; 10: 615-621.
104. Pappert EJ, Goetz CG, Vu TQ, et al. Animal model of posthypoxic myoclonus. Effects of serotonergic antagonists. Neurology 1999; 52: 16-21.